RBC
BSX icon

Romano Brothers & Co’s Boston Scientific BSX Stock Holding History

Romano Brothers & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$46.3K – 391
2022
Q4 		$46.3K Buy
+1,000
New +$43.3K 0.01% 482

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Romano Brothers & Co's BSX Position: Q1 2023 in Review

Romano Brothers & Co sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 1,000 shares — an estimated $46.3K sold.

Romano Brothers & Co first reported a position in BSX in Q4 2022 and held it in 1 quarter. The position peaked at $46.3K in Q4 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

  • Romano Brothers & Co reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
  • Romano Brothers & Co sold 1,000 Boston Scientific shares in Q1 2023, an estimated $46.3K.
  • Romano Brothers & Co first reported a position in Boston Scientific in Q4 2022 and held it in 1 quarter.
  • Romano Brothers & Co's Boston Scientific position peaked at $46.3K in Q4 2022.
  • 996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.